PharmaVoice

JUNE 27, 2025

FDA approvals dropped in May to 14 drugs after hitting 20 and above in the two months prior, but the total of 84 OKs so far in 2025 is the second only to 2024’s record high for the first part of the year, according to Clarivate. pharma is facing potential headwinds as the FDA’s attitude toward immunizations shifts under new leadership.

FDA 130

FDA Vaccines Packaging Dosage 130

Pharmaceutical Technology

JULY 22, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? PsO is an immune-mediated disease characterised by rapid skin cell proliferation leading to inflamed plaques that can cause discomfort or pain. Credit: design_cam/Shutterstock.com.

FDA 52

FDA Immunization Packaging Communication 52

Pharmaceutical Technology

JUNE 23, 2025

The European Commission (EC) has approved argenx’s Vyvgart (efgartigimod alfa) 1000mg as a single agent for subcutaneous injection to treat adults with chronic inflammatory demyelinating polyneuropathy (CIDP), an immune-mediated neuromuscular disorder of the peripheral nervous system.

Communication 52

Communication Hospitals Packaging Insurance 52

Pharmaceutical Technology

JUNE 6, 2025

This integration will reinforce Juvenescence’s pipeline in cardio-metabolism, cognition, immunity and cellular repair sectors. Incorporating Ro5’s AI platform into Juvenescence is expected to accelerate the development of AI-enabled treatments. Give your business an edge with our leading industry insights.

Communication 52

Communication Hospitals Packaging Compounding 52

Drug Topics

JUNE 27, 2025

In a vote of 5 to 1 on Thursday, members of the Advisory Committee on Immunization Practices (ACIP) voted to recommend against influenza vaccine containing the preservative thimerosal. 4 “The majority of children hospitalized with COVID-19 in October 2024 to March 2025 did not receive the most recently recommended COVID-19 vaccine,” he said.

Vaccines 405

Vaccines Independent Pharmacies Immunization Compounding 405

Pharmacy Times

JUNE 5, 2025

Detect-A-Dose lid-label cover enhances medication recognition, reducing packaging errors through a contrasting visual pattern. 2 A prominent aspect of this issue that manufacturers have tried to tackle is medication recognition when transferring pills to containers and packaging. 1-3 Detect-A-Dose Lid Label Covers.

Packaging 65

Packaging Labelling Compounding Pharmacies Immunization 65

Pharmaceutical Technology

JUNE 23, 2025

June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook HBM7020 activates immune system T cells to target and destroy B cells and plasma cells involved in many autoimmune diseases. In 2024, Otsuka announced the acquisition of US-based Jnana Therapeutics in a deal worth up to $1.1bn.

Communication 52

Communication Hospitals Packaging Insurance 52

PharmTech

JUNE 12, 2025

The warnings encompassed various forms of lack of compliance in the agency’s view, including product mislabeling, false or misleading claims on packaging, and shortfalls in current good manufacturing practice (CGMP) standards found during laboratory inspections. Implications of RFK Jr.’s Implications of RFK Jr.’s

FDA 59

FDA Dosage Compounding Labelling 59

Pharmacy Times

JULY 17, 2025

In 2024, an estimated 40.8 In June 2025, the White House submitted a formal rescissions package to Congress that proposed eliminating billions in foreign aid funding—including over $8 billion allocated to USAID. SHOW MORE Pharmacists play a vital role in translating global health news into actionable knowledge for their communities.

Vaccines 73

Vaccines Compounding Pharmacies Compounding Immunization 73

PharmTech

JUNE 10, 2025

I’m excited to see multispecific antibody- like biologics synergistically block multiple cancer cell survival pathways or help induce immune responses, such as cell-killing we are currently seeing with cell therapies,” Christian Cobaugh, chief scientific officer and founder, Vernal Biosciences, says.

Dosage 52

Dosage Vaccines Compounding Immunization 52

PharmaVoice

JUNE 25, 2025

The dual-mechanism biologic targets the overactive immune system, and leverages a combination of a low dose IL-2 and CTLA4-lg fusion protein to reduce inflammation through Treg cell enhancement. According to Swaminathan, targeting Tregs, a subset of T cells, may be key to reducing disease progression of ALS.

FDA 262

FDA Packaging Immunization 262

Drug Topics

JUNE 25, 2025

The properties of thimerosal were documented to contribute to the safe use of multidose vials and packaging of vaccines, such as seasonal and pandemic influenza vaccines. Further, in an analysis of flu vaccines in 2024, only 0.3% For children ages 6 years and younger, all vaccines routinely recommended do not contain thimerosal.

Vaccines 387

Vaccines Immunization Independent Pharmacies Compounding 387

Pharmaceutical Technology

JULY 8, 2025

Go deeper with GlobalData Reports LOA and PTSR Model - Briquilimab in Severe Combined Immune Deficien. Reports LOA and PTSR Model - Immune Globulin (Human) in Chronic Lymphocytic. Reports LOA and PTSR Model - Immune Globulin (Human) in Chronic Lymphocytic. How will RFK Jr’s American dream for vaccines play out?

Packaging 52

Packaging Immunization Hospitals Communication 52

The Thyroid Pharmacist

MARCH 7, 2025

1] This inability to detox properly can trigger or worsen autoimmune symptoms, as these chemical exposures can trigger immune dysregulation. [2] 7] A recent report from 2024 found that fluoride exposure is associated with lower IQ in children, which has brought the issue of fluoridation front and center again (the U.S.

Health and Personal Care Stores 67

Health and Personal Care Stores Labelling Immunization Packaging 67

Pharmaceutical Technology

JUNE 18, 2025

fired 17 sitting members of the Advisory Committee on Immunization Practices at the Centers for Disease Control and Prevention (CDC), concerns rose about the stance of federal agencies on vaccines. Give your business an edge with our leading industry insights.

FDA 52

FDA Vaccines Communication Hospitals 52

Pharmaceutical Technology

JULY 1, 2025

The US Food and Drug Administration (FDA) has approved Takeda’s new immunoglobulin (IG) therapy, Gammagard liquid ERC [immune globulin infusion (human)], to treat primary immunodeficiency (PI) in individuals aged two years and above. Credit: HenadziPechan/Shutterstock. Give your business an edge with our leading industry insights.

FDA 52

FDA Packaging Communication Hospitals 52

PharmTech

JUNE 12, 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines Feliza Mirasol April 30th 2024 Podcast In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Dosage 52

Dosage Vaccines Packaging Compounding 52

Pharmaceutical Technology

JULY 1, 2025

A preliminary look at the data from Capstan has revealed strong B-cell depletion – the aim of the treatment is to achieve an ‘immune reset’ by repopulation of healthy B cells. This is not the first in vivo CAR-T relationship that AbbVie has fostered, with a collaboration with Umoja Biopharma in January 2024. higher at $185.62

Packaging 52

Packaging Communication Hospitals FDA 52

Pharmaceutical Technology

JUNE 12, 2025

The biotech used these funds to establish a pipeline that includes three metabolic disease programmes, with further assets across immune disorders and endocrine diseases. Apple Tree Partners founded the Deep Apple in 2022, investing $52m in series A funding. Give your business an edge with our leading industry insights.

Compounding 59

Compounding Communication Hospitals Packaging 59

Pharmaceutical Technology

JULY 3, 2025

It comes with one for cytokine release syndrome (CRS) and neurologic toxicity – including immune effector cell-associated neurotoxicity syndrome – in addition to warnings and precautions for infections, neutropenia, hepatotoxicity and embryo-foetal toxicity. Tecvayli generated $549m in 2024 while Elrexfio secured $133m.

FDA 52

FDA Packaging Communication Hospitals 52

Pharmaceutical Technology

JUNE 20, 2025

Find out more This treatment involves obtaining immune cells from patients, modifying them in a laboratory setting then reintroducing them into patients’ bodies to destroy cancerous cells. Data Insights The gold standard of business intelligence. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate?

Hospitals 52

Hospitals Communication Immunization Packaging 52

Pharmaceutical Technology

JULY 14, 2025

A single dose of the vaccine in adults aged 18-49 at increased risk of RSV-LRTD elicited robust immune responses that were non-inferior to those observed in adults aged 60 and above. That is instead recommended by the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP).

Labelling 52

Labelling Vaccines FDA Packaging 52

Pharmaceutical Technology

JUNE 11, 2025

CD4+T-cells and lymphocytes are both crucial elements of the immune system. Antiviral Biktarvy is the company’s top-selling HIV drug, generating global revenue of $13.4bn in 2024, an increase of 13% compared to 2023. Low levels of either increase the likelihood of infections and other health problems.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents FDA Communication Hospitals 52

Pharmaceutical Technology

JULY 15, 2025

Robert Barrie July 15, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Hong Kong-listed Sino already owns a 4.91% stake courtesy of an investment in November 2024. Sino already owns a 4.91% stake courtesy of an investment in November 2024, with the company now seeking to purchase the remaining 95.09% it does not own.

Packaging 75

Packaging Communication Hospitals Vaccines 75

Pharmaceutical Technology

JULY 11, 2025

Its design minimises interaction with Fc-gamma (Fcγ) receptors on macrophages, enhancing the ability of the body’s immune cells to recognise and combat tumours. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging 52

Packaging Hospitals Communication Labelling 52

Pharmaceutical Technology

JUNE 16, 2025

Keytruda is designed to enhance the immune system’s ability to detect and combat tumour cells. Based on these trial results, Keytruda as part of this regimen shows potential to change long-standing standards of care for treating certain patients with locally advanced HNSCC.” Give your business an edge with our leading industry insights.

FDA 52

FDA Research Laboratories Communication Hospitals 52

Pharmaceutical Technology

JULY 4, 2025

Go deeper with GlobalData Reports LOA and PTSR Model - Briquilimab in Severe Combined Immune Deficien. Nominate Now Share Copy Link Share on X Share on Linkedin Share on Facebook Go deeper with GlobalData Reports LOA and PTSR Model - Briquilimab in Severe Combined Immune Deficien. How will RFK Jr’s American dream for vaccines play out?

Hospitals 52

Hospitals Packaging Communication Immunization 52

Pharmaceutical Technology

JULY 15, 2025

LEO’s new asset is a monoclonal antibody that blocks the activation of the interleukin-36 (IL-36) receptor – a key signalling pathway in the immune system implicated in the pathogenesis of several autoinflammatory diseases. How will RFK Jr’s American dream for vaccines play out?

Packaging 52

Packaging Communication Hospitals Vaccines 52

Pharmaceutical Technology

JUNE 13, 2025

Moderna’s vaccine, known under the brand name mRESVIA, became the first non-Covid-19 messenger RNA-based (mRNA) vaccine to be approved in the US in May 2024. That is instead decided by the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP).

Vaccines 52

Vaccines FDA Labelling Communication 52

PharmaVoice

JULY 2, 2025

In 2023 and 2024, approximately 30% of molecules in-licensed by Big Pharma companies came from China, Lansdell said. While many experts anticipated a further acceleration of 2024’s record-breaking deal making with Chinese companies, Lansdell said this year’s data shows it’s holding steady. “The

Packaging 130

Packaging FDA Immunization Vaccines 130

Pharmaceutical Technology

JUNE 10, 2025

The US department of Health and Human Services (HHS) has culled the 17 Biden-appointed members on the Advisory Committee for Immunization Practices (ACIP) at the Centers for Disease Control and Prevention (CDC) in a move observers warn is liable to further fuel the spread of vaccine-preventable illnesses. lev radin via Shutterstock.

Vaccines 52

Vaccines FDA Immunization Communication 52

Pharmaceutical Technology

JUNE 12, 2025

By GlobalData Learn more about Strategic Intelligence By covering a wide range of targets on malignant B cells, the therapy aims to enhance safety and efficacy while minimising the potential of tumour cells for developing immune-resistance mechanisms such as antigen escape. Give your business an edge with our leading industry insights.

Communication 52

Communication Hospitals Packaging Insurance 52

Pharmaceutical Technology

JUNE 25, 2025

In a controversial move on 9 June 2025, US Secretary of Health and Human Services Robert F Kennedy Jr dismissed all 17 members of the Centers for Disease Control and Prevention (CDC) Advisory Committee for Immunization Practices (ACIP) that advises the federal government on vaccine safety.

Vaccines 52

Vaccines Packaging Hospitals Communication 52

Pharmaceutical Technology

JUNE 25, 2025

RFK Jr has flip-flopped between endorsing and shunning the MMR vaccine , a shot that is proven to provide strong immunity against the disease. Give your business an edge with our leading industry insights.

Vaccines 116

Vaccines Hospitals Packaging Communication 116

Pharmaceutical Technology

JUNE 16, 2025

A low incidence of immune effector cell-associated neurotoxicity syndrome was reported during the step-up dosing phase and the target dose phase. Two patients experienced dose-limiting toxicities and continued to receive the targeted dose. Give your business an edge with our leading industry insights.

Labelling 52

Labelling Communication Hospitals Vaccines 52

PharmaVoice

JULY 11, 2025

In the decades before immunization was possible, 3 million to 4 million Americans were infected with measles each year. has been uneven in his support for immunizations. These insights give us a critical edge in responding to both emerging infectious threats and optimizing existing immunization strategies." Kennedy Jr.

Vaccines 214

Vaccines Immunization Insurance Packaging 214

PharmTech

JUNE 10, 2025

s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. ACIP plays a foundational role in shaping immunization policy in the US. Kennedy Jr.

Vaccines 85

Vaccines Dosage Packaging Immunization 85